S
Saules Seimos Medicinos Centras | Klinikinu Tyrimu Centras
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Tanezumab
KBP-5074
Olezarsen
Olpasiran
ISIS 678354
Evolocumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 7 total trials
Status recently updated
The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.
Enrolling
Active, not recruiting
Severe Hypertriglyceridemia
Drug: Olezarsen
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (C...
Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Olpasiran
Drug: Placebo
Trial sponsors
K
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems